Synaptogenix Inc./$TAOX
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
Ticker
$TAOX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
4
ISIN
US87167T3005
Website
TAOX Metrics
BasicAdvanced
$11M
-
-$9.90
1.29
-
Price and volume
Market cap
$11M
Beta
1.29
52-week high
$8.94
52-week low
$1.84
Average daily volume
1.8M
Financial strength
Current ratio
72.71
Quick ratio
70.412
Profitability
EBITDA (TTM)
-6.183
Management effectiveness
Return on assets (TTM)
-17.29%
Return on equity (TTM)
-83.05%
Valuation
Price to book
2.17
Price to tangible book (TTM)
2.17
Price to free cash flow (TTM)
-1.746
Free cash flow yield (TTM)
-57.26%
Free cash flow per share (TTM)
-462.65%
Growth
Earnings per share change (TTM)
-47.35%
3-year earnings per share growth (CAGR)
-42.83%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Synaptogenix Inc. stock?
Synaptogenix Inc. (TAOX) has a market cap of $11M as of July 04, 2025.
What is the P/E ratio for Synaptogenix Inc. stock?
The price to earnings (P/E) ratio for Synaptogenix Inc. (TAOX) stock is 0 as of July 04, 2025.
Does Synaptogenix Inc. stock pay dividends?
No, Synaptogenix Inc. (TAOX) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Synaptogenix Inc. dividend payment date?
Synaptogenix Inc. (TAOX) stock does not pay dividends to its shareholders.
What is the beta indicator for Synaptogenix Inc.?
Synaptogenix Inc. (TAOX) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.